Curaleaf Holdings (CURLF) Cash from Investing Activities (QoQ) (2019 - 2024)
Curaleaf Holdings (CURLF) Cash from Investing Activities (QoQ) (2019 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn |
| 10 | Curaleaf Holdings | 6.95 Bn | 6.95 Bn | 157.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 6.25% |
| Sep 30, 2024 | -100.16% |
| Jun 30, 2024 | 199.77% |
| Mar 31, 2024 | -85,187.97% |
| Dec 31, 2023 | -2.02% |
| Sep 30, 2023 | -100.08% |
| Jun 30, 2023 | 199.86% |
| Mar 31, 2023 | -69,973.66% |
| Dec 31, 2022 | 9.41% |
| Sep 30, 2022 | -26.32% |
| Jun 30, 2022 | 65.49% |
| Mar 31, 2022 | -16.23% |
| Dec 31, 2021 | -75.56% |
| Sep 30, 2021 | -2,154.19% |
| Jun 30, 2021 | 93.32% |
| Mar 31, 2021 | -17.69% |
| Dec 31, 2020 | -49,717.18% |
| Sep 30, 2020 | 99.93% |
| Jun 30, 2020 | -60.79% |
| Mar 31, 2020 | -76.11% |